Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of LY3002815 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ixekizumab in the Treatment of Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3337641 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AK-01 (LY3295668) in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of LY3337641 in Japanese and Caucasian Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE1